Detalhe da pesquisa
1.
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Br J Cancer
; 129(6): 965-973, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537253
2.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451345
3.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310714
4.
Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.
Br J Clin Pharmacol
; 87(1): 178-188, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436239
5.
Multivariate binary classification of imbalanced datasets-A case study based on high-dimensional multiplex autoimmune assay data.
Biom J
; 59(5): 948-966, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28626952